DUBLIN,
Ohio, Feb. 28, 2024 /PRNewswire/ -- Cardinal
Health (NYSE: CAH) announced today that its Board of Directors has
elected Robert "Bob" Azelby as an independent director,
effective March 1. Mr. Azelby joins the board with over 30
years of experience, including as a Chief Executive Officer and
board member for large, matrixed organizations in the
biopharmaceutical, oncology and other specialty industries.
Mr. Azelby has previously served as President and Chief
Executive Officer of Eliem Therapeutics, and prior to Eliem, he was
the Chief Executive Officer of Alder BioPharmaceuticals. Before
joining Alder BioPharmaceuticals, Mr. Azelby was the Chief
Commercial Officer of Juno Therapeutics, and served 15 years in a
variety of commercial roles at Amgen.
Mr. Azelby currently serves on the Boards of Directors of ADC
Therapeutics and Autolus Therapeutics. He also formerly served on
the Boards of Directors for Chinook Therapeutics, Eliem
Therapeutics, Clovis Oncology, Immunomedics, Alder
BioPharmaceuticals, and Cascadian Therapeutics.
"Bob Azelby is a highly respected
healthcare industry leader with a strong track record of leading
large, complex organizations as both a CEO and a board member,"
said Greg Kenny, Chairman of the
Board for Cardinal Health. "Bob's vast experience and expertise
within the specialty pharmaceutical arena will add great value to
our company and we're pleased to welcome him to our board."
"Bob brings to our board more than three decades of experience
and high performance across a multitude of healthcare industries,
including oncology and other specialty areas, which I believe will
make him a uniquely valuable addition," said Jason Hollar, CEO of Cardinal Health. "We look
forward to tapping into Bob's extensive expertise as we continue
the momentum against our strategic priorities."
Mr. Azelby holds a BA in Economics and Religious Studies from
the University of Virginia and an MBA
from Harvard Business School.
About Cardinal Health
Cardinal Health is a distributor
of pharmaceuticals, a global manufacturer and distributor of
medical and laboratory products, and a provider of performance and
data solutions for healthcare facilities. With more than 50 years
in business, operations in more than 30 countries and
approximately 48,000 employees globally, Cardinal Health is
essential to care. Information about Cardinal Health is available
at cardinalhealth.com.
Contacts
Media: Erich
Timmerman, erich.timmerman@cardinalhealth.com and
614.757.8231
Investors: Matt Sims,
matt.sims@cardinalhealth.com and 614.553.3661
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bob-azelby-to-join-cardinal-health-board-of-directors-302074485.html
SOURCE Cardinal Health